Dolby Laboratories (NYSE:DLB) Receives Average Recommendation of “Moderate Buy” from Analysts

Dolby Laboratories (NYSE:DLB) has been given a consensus rating of “Moderate Buy” by the five brokerages that are covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $90.75.

A number of analysts have recently commented on the company. Rosenblatt Securities reaffirmed a “buy” rating and issued a $85.00 price target on shares of Dolby Laboratories in a research note on Thursday, June 11th. Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Wednesday, June 24th. Barrington Research reaffirmed an “outperform” rating and issued a $90.00 target price on shares of Dolby Laboratories in a research note on Monday, June 15th. Finally, Wall Street Zen upgraded shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Saturday, May 30th.

Dolby Laboratories Stock Performance

Shares of Dolby Laboratories stock opened at $51.36 on Tuesday. The firm has a fifty day moving average of $52.30 and a two-hundred day moving average of $58.83. The stock has a market capitalization of $4.86 billion, a price-to-earnings ratio of 20.30 and a beta of 0.81. Dolby Laboratories has a 52 week low of $48.26 and a 52 week high of $76.70.

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings data on Thursday, April 30th. The electronics maker reported $1.37 EPS for the quarter, beating analysts’ consensus estimates of $1.31 by $0.06. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The business had revenue of $395.63 million during the quarter, compared to the consensus estimate of $385.80 million. During the same quarter in the prior year, the company posted $1.34 earnings per share. The firm’s revenue was up 7.0% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. As a group, research analysts forecast that Dolby Laboratories will post 3.21 EPS for the current fiscal year.

Insiders Place Their Bets

In other Dolby Laboratories news, CFO Robert J. Park sold 4,895 shares of the stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $56.68, for a total value of $277,448.60. Following the completion of the sale, the chief financial officer directly owned 81,490 shares in the company, valued at $4,618,853.20. This represents a 5.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP John D. Couling sold 7,667 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $53.20, for a total value of $407,884.40. Following the sale, the senior vice president directly owned 118,727 shares in the company, valued at approximately $6,316,276.40. This represents a 6.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 47,458 shares of company stock worth $2,639,537. 37.93% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Dolby Laboratories

Several institutional investors and hedge funds have recently modified their holdings of the business. Fifth Third Bancorp increased its stake in Dolby Laboratories by 34.7% during the 4th quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock worth $48,000 after purchasing an additional 192 shares in the last quarter. Aquatic Capital Management LLC bought a new position in Dolby Laboratories in the third quarter valued at approximately $56,000. iSAM Funds UK Ltd bought a new stake in shares of Dolby Laboratories during the third quarter worth $68,000. Allworth Financial LP increased its position in shares of Dolby Laboratories by 99.6% during the third quarter. Allworth Financial LP now owns 1,006 shares of the electronics maker’s stock worth $73,000 after acquiring an additional 502 shares in the last quarter. Finally, Quarry LP raised its holdings in shares of Dolby Laboratories by 1,486.7% during the fourth quarter. Quarry LP now owns 1,190 shares of the electronics maker’s stock worth $76,000 after acquiring an additional 1,115 shares during the period. 58.56% of the stock is currently owned by institutional investors and hedge funds.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.